Abiopharma

🔍 Hashad Yehia (Executive)

Company: Bausch & Lomb Corp (BLCO)

Report Date: 2026-08-05

Detailed Transactions and Holdings:

• Acquired 20,973 shares of Common Shares, No Par Value (Direct)
  Date: 2026-08-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 187,350.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on February 28, 2024 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, subject generally to the reporting person's continued employment through such date.